These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10397494)
1. Nitroquinolones with broad-spectrum antimycobacterial activity in vitro. Artico M; Mai A; Sbardella G; Massa S; Musiu C; Lostia S; Demontis F; La Colla P Bioorg Med Chem Lett; 1999 Jun; 9(12):1651-6. PubMed ID: 10397494 [TBL] [Abstract][Full Text] [Related]
2. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone. Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163 [TBL] [Abstract][Full Text] [Related]
3. Preliminary study of the in vitro activity of irloxacin against mycobacteria. Casal M; Gutierrez J; Ruiz P; Moreno G Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667 [TBL] [Abstract][Full Text] [Related]
4. New 6-nitroquinolones: synthesis and antimicrobial activities. Sbardella G; Mai A; Artico M; Setzu MG; Poni G; La Colla P Farmaco; 2004 Jun; 59(6):463-71. PubMed ID: 15178309 [TBL] [Abstract][Full Text] [Related]
6. MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis. Heifets LB; Lindholm-Levy PJ Antimicrob Agents Chemother; 1990 May; 34(5):770-4. PubMed ID: 2113793 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Renau TE; Gage JW; Dever JA; Roland GE; Joannides ET; Shapiro MA; Sanchez JP; Gracheck SJ; Domagala JM; Jacobs MR; Reynolds RC Antimicrob Agents Chemother; 1996 Oct; 40(10):2363-8. PubMed ID: 8891145 [TBL] [Abstract][Full Text] [Related]
8. Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships. Araki K; Kuroda T; Uemori S; Moriguchi A; Ikeda Y; Hirayama F; Yokoyama Y; Iwao E; Yakushiji T J Med Chem; 1993 May; 36(10):1356-63. PubMed ID: 8388467 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives. Foroumadi A; Soltani F; Moshafi MH; Ashraf-Askari R Farmaco; 2003 Oct; 58(10):1023-8. PubMed ID: 14505733 [TBL] [Abstract][Full Text] [Related]
10. Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum. Guillemin I; Sougakoff W; Cambau E; Revel-Viravau V; Moreau N; Jarlier V Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2527-2532. PubMed ID: 10517605 [TBL] [Abstract][Full Text] [Related]
11. [Synthesis and antibacterial activity of 5-amino-6, 8-difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues]. Liu JY; Wei YG; Guo HY Yao Xue Xue Bao; 2001 Jun; 36(6):419-22. PubMed ID: 12585124 [TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. Fung-Tomc J; Minassian B; Kolek B; Washo T; Huczko E; Bonner D J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819 [TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro and in vivo evaluation of quinolones with selective activity against gram-positive organisms. Cooper CS; Klock PL; Chu DT; Hardy DJ; Swanson RN; Plattner JJ J Med Chem; 1992 Apr; 35(8):1392-8. PubMed ID: 1573632 [TBL] [Abstract][Full Text] [Related]
14. New trifluoromethyl quinolone derivatives: synthesis and investigation of antimicrobial properties. Panda SS; Jain SC Bioorg Med Chem Lett; 2013 Jun; 23(11):3225-9. PubMed ID: 23611733 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of 1-(substituted pyrrolyl)-7-(substituted amino)-6-fluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids. Liu JH; Guo HY J Med Chem; 1992 Sep; 35(19):3469-73. PubMed ID: 1404228 [TBL] [Abstract][Full Text] [Related]
16. Fluorocyclopropyl quinolones. 1. Synthesis and structure-activity relationships of 1-(2-fluorocyclopropyl)-3-pyridonecarboxylic acid antibacterial agents. Atarashi S; Imamura M; Kimura Y; Yoshida A; Hayakawa I J Med Chem; 1993 Oct; 36(22):3444-8. PubMed ID: 8230135 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756). Hayashi K; Takahata M; Kawamura Y; Todo Y Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531 [TBL] [Abstract][Full Text] [Related]
18. Imidazo- and triazoloquinolones as antibacterial agents. Synthesis and structure-activity relationships. Fujita M; Egawa H; Kataoka M; Miyamoto T; Nakano J; Matsumoto J Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2123-32. PubMed ID: 8582014 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of quinolones and macrolides against mycobacteria. Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409 [TBL] [Abstract][Full Text] [Related]